S-RACMO

S-RACMO is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the field of regenerative medicine and cell therapy. Formed as a joint venture between Sumitomo Corporation and Kyowa Kirin, the company combines Kyowa Kirin's deep technical expertise in biopharmaceutical manufacturing with Sumitomo's extensive global infrastructure. S-RACMO offers a range of services including process development, manufacturing of clinical trial materials, and commercial-scale production of cell-based products. The company's facility in Takasaki, Japan, is designed to comply with international GMP standards, supporting the global development of advanced therapies. By providing high-quality manufacturing solutions, S-RACMO aims to accelerate the delivery of innovative regenerative treatments to patients worldwide.